Thrombotic microangiopathies: towards a pathophysiology-based classification, Cardiovasc Hematol Disord Drug Targets, vol.9, pp.36-50, 2009. ,
Autoimmune thrombotic microangiopathy: advances in pathogenesis, diagnosis, and management, Semin Thromb Hemost, vol.38, pp.469-82, 2012. ,
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura, Nature, vol.413, pp.488-94, 2001. ,
Endothelial cells and thrombotic microangiopathy, Semin Nephrol, vol.32, pp.208-222, 2012. ,
The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis, Blood, vol.111, pp.3452-3459, 2008. ,
Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice, J Clin Invest, vol.115, pp.2752-61, 2005. ,
A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13, Blood, vol.119, pp.6128-6163, 2012. ,
Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study, J Thromb Haemost, vol.12, pp.1601-1610, 2014. ,
Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases, Arch Pathol Lab Med, vol.127, pp.834-843, 2003. ,
The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. A clinicopathologic study of 17 autopsied patients, Ann Intern Med, vol.91, pp.357-63, 1979. ,
Report of 25 cases and review of the literature. Medicine (Baltimore), vol.60, pp.413-441, 1981. ,
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura, Blood, vol.11, pp.1746-53, 2011. ,
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French thrombotic microangiopathies reference center, French Thrombotic Microangiopathies Reference Center, vol.40, pp.104-115, 2012. ,
Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French thrombotic microangiopathies reference center, J Thromb Haemost, vol.13, pp.293-302, 2015. ,
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience, Thrombotic Microangiopathies Reference Center, vol.97, pp.1181-1187, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00700485
Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group, N Engl J Med, vol.325, pp.393-400, 1991. ,
Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients, N Engl J Med, vol.325, pp.398-403, 1991. ,
Thrombotic thrombocytopenic purpura, N Engl J Med, vol.354, pp.1927-1962, 2006. ,
Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience, PLoS ONE, vol.5, p.10208, 2010. ,
Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review, Transfusion (Paris), vol.48, pp.382-92, 2008. ,
Cardiac manifestations of thrombotic thrombocytopenic purpura, Neth J Med, vol.35, pp.100-107, 1989. ,
Incidence and prognosis of acute heart failure in the thrombotic microangiopathies, Am J Med, vol.118, pp.544-551, 2005. ,
Cardiovascular manifestations in patients with thrombotic thrombocytopenic purpura: a single-center experience, Clin Cardiol, vol.33, pp.213-229, 2010. ,
Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13, J Thromb Haemost, vol.7, pp.529-565, 2009. ,
Selective vascular endothelial protection reduces cardiac dysfunction in chronic heart failure, Circ Heart Fail, vol.9, p.2895, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02296623
FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay, Br J Haematol, vol.129, pp.93-100, 2005. ,
A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis, Proc Natl Acad Sci, vol.95, pp.9524-9533, 1998. ,
Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B, J Mol Cell Cardiol, vol.52, pp.1257-64, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00801304
Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure, Circulation, vol.124, pp.1059-69, 2011. ,
Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure, J Mol Cell Cardiol, vol.52, pp.660-666, 2012. ,
Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice, FASEB J, vol.28, pp.3351-61, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02142777
Magnetization exchange in capillaries by microcirculation affects diffusion-controlled spin-relaxation: a model which describes the effect of perfusion on relaxation enhancement by intravascular contrast agents, Magn Reson Med, vol.35, pp.43-55, 1996. ,
High-resolution myocardial perfusion mapping in small animals in vivo by spin-labeling gradient-echo imaging, Magn Reson Med, vol.51, pp.62-69, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-02119122
Joannid es R. Role of Toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome, Arthritis Rheumatol, vol.66, pp.3210-3230, 2014. ,
Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction, Arterioscler Thromb Vasc Biol, vol.27, pp.1064-71, 2007. ,
In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats, Circulation, vol.91, pp.771-776, 1995. ,
Cardiac injury is a common postmortem finding in thrombotic thrombocytopenic purpura patients: is empiric cardiac monitoring and protection needed?, Ther Apher Dial, vol.19, pp.87-92, 2015. ,
Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus), Blood, vol.116, pp.2005-2015, 2010. ,
Acute myocardial infarction in thrombotic microangiopathies -clinical characteristics, risk factors and outcome, Nephrol Dial Transplant, vol.21, pp.1549-54, 2006. ,
Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells, Blood, vol.89, pp.1224-1258, 1997. ,
Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortality, Arterioscler Thromb Vasc Biol, vol.34, pp.1032-1076, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02296639
Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin, Circulation, vol.102, pp.351-357, 2000. ,
Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms, Am J Physiol, vol.267, pp.1921-1928, 1994. ,
Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases, Circulation, vol.127, pp.1317-1346, 2013. ,
Induction of heme-oxygenase-1 prevents the systemic responses to hemorrhagic shock, Am J Respir Crit Care Med, vol.164, pp.1933-1941, 2001. ,
Oxidant stress leads to transcriptional activation of the human heme oxygenase gene in cultured skin fibroblasts, Mol Cell Biol, vol.10, pp.4967-4976, 1990. ,
Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite, Proc Natl Acad Sci, vol.86, pp.99-103, 1989. ,
Ultraviolet A (320-380 nm) radiation causes an alteration in the binding of a specific protein/protein complex to a short region of the promoter of the human heme oxygenase 1 gene, Nucleic Acids Res, vol.21, pp.1103-1112, 1993. ,
Human sickle cell blood modulates endothelial heme oxygenase activity: effects on vascular adhesion and reactivity, Arterioscler Thromb Vasc Biol, vol.30, pp.305-317, 2010. ,
Pretorius M. Heme oxygenase-1 and acute kidney injury following cardiac surgery, Cardiorenal Med, vol.4, pp.12-21, 2014. ,
Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology, Arterioscler Thromb Vasc Biol, vol.20, pp.2175-83, 2000. ,
Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system, Circ Res, vol.110, pp.1364-90, 2012. ,
NOX2-induced myocardial fibrosis and diastolic dysfunction: role of the endothelium, J Am Coll Cardiol, vol.63, pp.2742-2746, 2014. ,
Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase, Circulation, vol.106, pp.3073-3081, 2002. ,
The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide, Br J Pharmacol, vol.92, pp.639-685, 1987. ,
Exogenous nitric oxide inhibits VCAM-1 expression in human peritoneal mesothelial cells. Role of cyclic GMP and NF-kappaB, Nephron, vol.90, pp.447-54, 2002. ,
Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease, Br J Haematol, vol.112, pp.81-90, 2001. ,
Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium, Hypertension, vol.51, pp.915-936, 2008. ,
Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice, J Cereb Blood Flow Metab, vol.26, pp.421-453, 2006. ,